Overview

Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients

Status:
Withdrawn
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The primary aim is to determine whether Divalproex ER or one of the atypical antipsychotics is more effective improving dementia related behavioral symptoms in patients with dementia, and evaluate the impact of such improvements on other clinical domains, such as quality of life, functional status.
Phase:
Phase 4
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
Abbott
Treatments:
Quetiapine Fumarate
Valproic Acid